Thyrotropin Alfa injection
What is this medicine?
THYROTROPIN ALFA (thahy ruh TROH pin AL fa) is a man-made protein. It is used to diagnose any remaining thyroid cancer after treatment. It is also used to help treat thyroid cancer.
How should I use this medicine?
This medicine is for injection into a muscle. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
signs and symptoms of a stroke like changes in vision; confusion; trouble speaking or understanding; severe headaches; sudden numbness or weakness of the face, arm or leg; trouble walking; dizziness; loss of balance or coordination
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
weak or tired
What may interact with this medicine?
Interactions are not expected.
What if I miss a dose?
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
cancer that has spread to other parts of the body
have thyroid tissue remaining
an unusual or allergic reaction to thyrotropin, thyroid products, other hormones, medicines, foods, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Visit your doctor or health care professional regularly. Your condition will be monitored carefully while you are receiving this medicine. You may need blood work done while you are taking this medicine.
September 30, 2017